Lebrikizumab, CAS [[953400-68-5]]

Product Overview

• Article Name: Lebrikizumab, CAS [[953400-68-5]]
• Biozol Catalog Number: MCE-HY-P99025
• Supplier Catalog Number: HY-P99025
• Alternative Catalog Number: MCE-HY-P99025-100MG,MCE-HY-P99025-50MG,MCE-HY-P99025-25MG,MCE-HY-P99025-5MG,MCE-HY-P99025-1MG,MCE-HY-P99025-10MG
• Manufacturer: MedchemExpress
• Category: Antikörper
• Alternative Names: TNX-650, MILR1444A, RG3637

Product Description

Lebrikizumab (TNX-650) is an IgG4 humanized anti-interleukin-13 (IL-13) mAb with anti-itch effects that specifically binds to IL-13 in a non-receptor binding domain and inhibits its function. Lebrikizumab inhibits the IL-13 driven Th2 inflammatory response and blocks the signaling of IL-4Ralpha/IL-13Ralpha1. Lebrikizumab can be used for the research of asthma, atopic dermatitis and neuroinflammatory diseases[1][2][3].

Product Properties

• Molecular Weight: (145.318 kDa)
• Purity: 99.90
• CAS Number: [953400-68-5]
• Target: Interleukin Related

Application Notes

• Application Notes: MCE Product type: Inhibitory Antibodies